Nasdaq Lists Canary’s Staked INJ ETF, Adding Another Route to Altcoin Exposure

TL;DR: Nasdaq began listing the Canary Staked INJ ETF under ticker INJC on November 5, according to the exchange’s listing notice and Canary Capital. The product seeks Injective token exposure and staking rewards, but fund ownership is not the same as directly holding or controlling INJ. US exchange-traded cryptocurrency products are extending well beyond Bitcoin and Ether. Nasdaq’s November 4 trader notice confirmed that the Canary Staked INJ ETF would be listed starting Thursday, November 5, under the ticker INJC. Canary Capital’s launch announcement describes the fund’s aim as exposure to INJ, the native token of the Injective network, together with an ability to earn staking rewards. That gives investors a new route into a smaller cryptocurrency using a familiar brokerage account. It also adds a layer of product structure and fees that should not be confused with direct ownership of tokens in a self-custodied wallet. Price exposure and staking in one wrapper Injective operates a proof-of-stake blockchain. In proof-of-stake networks, eligible token holders can participate in network validation, often by delegating tokens to validators, and may receive rewards. A staked fund seek...